Figure 6
Figure 6. Some Gag- and Nef-specific CTLs cells do not require de novo viral protein synthesis for early killing of HIV-1–infected cells. 1CC4.14 cells were infected with 600 fg of Gag p24/cell of VSV-G Env-pseudotyped NL4-3-ΔEnv-HSA and assessed for killing by CTLs (51Cr release) in the presence and absence of ART. (A) Uninfected or infected cells with or without ART were examined by flow cytometry for cell-surface expression of HLA A*02 and HSA reporter at 48 hours after infection, confirming that ART blocked the de novo viral protein expression seen in untreated cells (HSA expression and A*02 down-regulation by Nef). (B) Specific lysis of uninfected or infected target cells (with or without ART) was assessed by 51Cr-release assay over time. The data shown are representative of 2 independent experiments.

Some Gag- and Nef-specific CTLs cells do not require de novo viral protein synthesis for early killing of HIV-1–infected cells. 1CC4.14 cells were infected with 600 fg of Gag p24/cell of VSV-G Env-pseudotyped NL4-3-ΔEnv-HSA and assessed for killing by CTLs (51Cr release) in the presence and absence of ART. (A) Uninfected or infected cells with or without ART were examined by flow cytometry for cell-surface expression of HLA A*02 and HSA reporter at 48 hours after infection, confirming that ART blocked the de novo viral protein expression seen in untreated cells (HSA expression and A*02 down-regulation by Nef). (B) Specific lysis of uninfected or infected target cells (with or without ART) was assessed by 51Cr-release assay over time. The data shown are representative of 2 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal